Competition is supposed to keep prices down, so why did the cost of emergency allergy treatment EpiPen continue to soar after the introduction of a competing product? Because, according to a new lawsuit, most of that added money was going to intermediaries who could make sure that EpiPen remained the preferred (and sometimes only) drug of its kind on insurance plans. [More]
Auvi-q
Lawsuit: EpiPen Price Hikes Were Intended To Keep Competitor Out Of Pharmacies
By 4.26.17 — Updated: 5.9.17
The EpiPen Generic Is Finally Here, For $300 Per Twin-Pack
By 12.16.16
A day after Mylan was one of six pharmaceutical companies named in a multi-state lawsuit alleging price-fixing on generic drugs, the maker of high-priced emergency allergy treatment EpiPen announced that the generic version of the popular epinephrine auto-injector is finally hitting the market, giving people a lower-cost (but still pricey) option for buying the drug. [More]
Mylan To Start Selling $300 Generic EpiPen Pack Next Month
By 11.10.16
Under pressure to reduce the price of its expensive EpiPen emergency allergy treatment, drugmaker Mylan said in August that it would be introducing a generic version of the drug at half the retail price. Now it looks like the less-costly epinephrine auto-injector will be hitting the market after Thanksgiving.
EpiPen Competitor Auvi-Q Relaunching Next Year
By 10.26.16 — Updated: 10.31.16
Almost exactly a year after pharmaceutical maker Sanofi recalled nearly 500,000 epinephrine injectors after finding they might not provide the correct dosage to patients, the product is gearing up for a comeback, potentially creating a less expensive competitor to the highly scrutinized EpiPen. [More]
The Cost Of A Life-Saving EpiPen Has Increased 400% Since 2007
By 8.19.16
If you or someone in your family has severe allergies, the EpiPen is a familiar and essential product. Yet if you have good health insurance, what you may not know is that the cost of the pens has increased significantly since pharmaceutical giant Mylan acquired the drug in 2007. [More]
Drugmaker Recalls Nearly 500,000 Epinephrine Injectors Used To Treat Allergic Reactions
By 10.29.15
When you or someone you know suffers a severe allergy reaction, the quick use of an epinephrine injector is likely needed. But one drugmaker says it’s recalling tens of thousands of those devices because they might not work correctly. [More]
